Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Brachytherapy|March 3, 2018
Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancerAmandeep S Taggar, Kenneth L Pitter, Gil'ad N Cohen, et al.
Clinical Lung Cancer|September 1, 2015
Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung CancerLeonard T Ong, Mark Dunphy, Amanda Foster, et al.
Frontiers in Oncology|August 28, 2020
Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-MacroglobulinDonata von Reibnitz, Ellen D Yorke, Jung Hun Oh, et al.
Cancer Medicine|May 7, 2021
Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysisKrupa S Jani, Shou-En Lu, James D Murphy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2024
Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancerMatthew T McMillan, Annemarie Shepherd, Alissa J Cooper, et al.
International Journal of Cancer|December 27, 2022
Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomyThomas Boerner, Rebecca A Carr, Meier Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2021
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant TumorsNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Pageof 15